J&J Units Target Impax Over Generic Concerta
Two Johnson & Johnson units have fired off a suit seeking to block Impax Laboratories Inc. from launching a generic version of attention deficit disorder treatment Concerta....To view the full article, register now.
Already a subscriber? Click here to view full article